Stocks
GlaxoSmithKline (GSK) Market cap US GAAP (year values)The current market cap of the company GlaxoSmithKline is 102 666 960 000 £. |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Market cap, £ | 141 473 640 000 | 152 353 660 000 | 75 083 560 000 | 68 942 070 000 | 49 665 260 000 | 102 666 960 000 | |||
| Changes by years, y/y, % | +100% | +8% | -51% | -8% | -28% | -7.5% | |||
GlaxoSmithKline. Market cap, £
GlaxoSmithKline: рыночная капитализация + чистый долг (EV для GlaxoSmithKline), £
GlaxoSmithKline. Market cap, changes, %
GlaxoSmithKline (GSK) Market cap US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Market cap, £ | 79 184 560 000 | 78 009 600 000 | 87 053 720 000 | 49 272 940 000 | 111 014 685 000 | 102 666 960 000 | ||
| Changes by years, y/y, % | -9% | -50% | +4% | -29% | +40% | |||
| Changes by quarters, q/q, % | +15% | -1% | +12% | -43% | +125% | |||
